Citations (120)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ugne Meskauskaite, Silvija Andruskeviciute, Ieva Ciapiene, Agne Giedraitiene, Vaiva Lesauskaite & Vacis Tatarunas. (2022) Pleiotropic Effects of Ticagrelor: Influence on CYP4F2 Gene and Protein Expression in HUVEC and HepG2, and Escherichia coli Bacterial Survival. Drug Design, Development and Therapy 16, pages 2559-2568.
Read now
Read now
Mehmet Koray Adali, Ipek Buber, Oguz Kilic, Anil Turkoz & Samet Yilmaz. (2022) Ticagrelor improves systemic immune-inflammation index in acute coronary syndrome patients. Acta Cardiologica 77:7, pages 632-638.
Read now
Read now
Thomas A. Nelson, William A.E. Parker, Tatevik Ghukasyan Lakic, Johan Westerbergh, Stefan K. James, Agneta Siegbahn, Richard C. Becker, Anders Himmelmann, Lars Wallentin & Robert F. Storey. (2022) Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy. Platelets 33:3, pages 425-431.
Read now
Read now
William A. E. Parker & Robert F. Storey. (2021) Novel approaches to P2Y12 inhibition and aspirin dosing. Platelets 32:1, pages 7-14.
Read now
Read now
Dario Calderone, Davide Capodanno & Dominick J. Angiolillo. (2020) An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus. Expert Review of Cardiovascular Therapy 18:8, pages 449-464.
Read now
Read now
Rocco P. Milluzzo, Gabriele A. Franchina, Davide Capodanno & Dominick J. Angiolillo. (2020) Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development. Expert Opinion on Investigational Drugs 29:6, pages 537-546.
Read now
Read now
William A. E. Parker, Niclas Eriksson, Richard C. Becker, Deepak Voora, Axel Åkerblom, Anders Himmelmann, Stefan K. James, Lars Wallentin & Robert F. Storey. (2019) Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. Platelets 30:5, pages 579-588.
Read now
Read now
Xiuhua Li, Yusheng Li, Kan Shen, Hongqiang Li & Jianwen Bai. (2019) The protective effect of ticagrelor on renal function in a mouse model of sepsis-induced acute kidney injury. Platelets 30:2, pages 199-205.
Read now
Read now
Michał J Kubisa, Mateusz P Jezewski, Aleksandra Gasecka, Jolanta M Siller-Matula & Marek Postuła. (2018) Ticagrelor – toward more efficient platelet inhibition and beyond. Therapeutics and Clinical Risk Management 14, pages 129-140.
Read now
Read now
Karolina Akinosoglou, Angelos Perperis, Spyridoula Theodoraki, Dimitrios Alexopoulos & Charalambos Gogos. (2018) Sepsis favors high-on-clopidogrel platelet reactivity. Platelets 29:1, pages 76-78.
Read now
Read now
Erik L Grove, Morten Würtz, Mark R Thomas & Steen Dalby Kristensen. (2015) Antiplatelet therapy in acute coronary syndromes. Expert Opinion on Pharmacotherapy 16:14, pages 2133-2147.
Read now
Read now
Mark R. Thomas & Robert F. Storey. (2015) The future of P2Y12 receptor antagonists. Platelets 26:5, pages 392-398.
Read now
Read now
Articles from other publishers (108)
Helena Martínez-Sellés & Manuel Martínez-Sellés. (2023) Ticagrelor Antibiotic Effect. JACC: Basic to Translational Science 8:11, pages 1454-1456.
Crossref
Crossref
Elisabetta Cacace, Vladislav Kim, Vallo Varik, Michael Knopp, Manuela Tietgen, Amber Brauer-Nikonow, Kemal Inecik, André Mateus, Alessio Milanese, Marita Torrissen Mårli, Karin Mitosch, Joel Selkrig, Ana Rita Brochado, Oscar P. Kuipers, Morten Kjos, Georg Zeller, Mikhail M. Savitski, Stephan Göttig, Wolfgang Huber & Athanasios Typas. (2023) Systematic analysis of drug combinations against Gram-positive bacteria. Nature Microbiology 8:11, pages 2196-2212.
Crossref
Crossref
Bruna Gigante, Jerrold H Levy, Eric van Gorp, Alessandro Bartoloni, Marie-Luce Bochaton-Piallat, Magnus Bäck, Hugo ten Cate, Christina Christersson, José Luis Ferreiro, Tobias Geisler, Esther Lutgens, Sam Schulman, Robert F Storey, Jecko Thachil, Gemma Vilahur, Patricia C Liaw & Bianca Rocca. (2023) Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis. European Heart Journal 44:32, pages 3040-3058.
Crossref
Crossref
Risa Ueda & Hiromitsu Kataoka. (2023) The potential of the antiplatelet agent ticagrelor as a new antibacterial agent. Revista Médica de Risaralda 29:1.
Crossref
Crossref
Emmanuel Boadi Amoafo, Philomena Entsie, Ying Kang, Ilaria Canobbio & Elisabetta Liverani. (2023)
Platelet P2Y
12
signaling pathway in the dysregulated immune response during sepsis
. British Journal of Pharmacology.
Crossref
Crossref
David A. Zidar, Sadeer Al-Kindi, Chris T. Longenecker, Sahil A. Parikh, Carl B. Gillombardo, Nicholas T. Funderburg, Steven Juchnowski, Lauren Huntington, Trevor Jenkins, Christopher Nmai, Michael Osnard, Mehdi Shishebhor, Steven Filby, Curtis Tatsuoka, Michael M. Lederman, Eugene Blackstone, Guilherme Attizzani & Daniel I. Simon. (2023) Platelet and Monocyte Activation After Transcatheter Aortic Valve Replacement (POTENT-TAVR): A Mechanistic Randomized Trial of Ticagrelor Versus Clopidogrel. Structural Heart 7:4, pages 100182.
Crossref
Crossref
Mustapha Abdeljalil Braï, Nadji Hannachi, Nabila El Gueddari, Jean-Pierre Baudoin, Abderrhamane Dahmani, Hubert Lepidi, Gilbert Habib & Laurence Camoin-Jau. (2023) The Role of Platelets in Infective Endocarditis. International Journal of Molecular Sciences 24:8, pages 7540.
Crossref
Crossref
Chris A. Gentry, Charles M. Whitman, Brian S. Kliewer, Riley J. WilliamsIIII & Sharanjeet K. Thind. (2023) Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia. International Journal of Antimicrobial Agents 61:4, pages 106752.
Crossref
Crossref
Chris A. Gentry, Riley J. WilliamsIIII, Charles M. Whitman, Sharanjeet K. Thind & Brian S. Kliewer. (2023) Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel. International Journal of Antimicrobial Agents 61:4, pages 106743.
Crossref
Crossref
Nishank Jain, Adam Corken, John M. Arthur, Jerry Ware, Narenraj Arulprakash, Junqiang Dai, Milind A. Phadnis, Otis Davis, Yasir Rahmatallah, J.L. Mehta, S. Susan Hedayati & Susan Smyth. (2023) Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascular Pharmacology 148, pages 107143.
Crossref
Crossref
Xiaohua Li, Guoxing Zhang & Xia Cao. (2021) The Function and Regulation of Platelet P2Y12 Receptor. Cardiovascular Drugs and Therapy 37:1, pages 199-216.
Crossref
Crossref
Shu-hui Wang, Meng-jin Sun, Si-yue Ding, Chun-li Liu, Jing-min Wang, Sheng-na Han, Xi Lin & Qian Li. (2023) Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Hana Seung, Jan Wrobel, Carolin Wadle, Timon Bühler, Diana Chiang, Jasmin Rettkowski, Nina Cabezas-Wallscheid, Béatrice Hechler, Peter Stachon, Alexander Maier, Christian Weber, Dennis Wolf, Daniel Duerschmied, Marco Idzko, Christoph Bode, Constantin von zur Mühlen, Ingo Hilgendorf & Timo Heidt. (2022) P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction. Basic Research in Cardiology 117:1.
Crossref
Crossref
Jeffrey Triska, Neil Maitra, Matthew R. Deshotels, Faris Haddadin, Dominick J. Angiolillo, Gemma Vilahur, Hani Jneid, Dan Atar & Yochai Birnbaum. (2022) A Comprehensive Review of the Pleiotropic Effects of Ticagrelor. Cardiovascular Drugs and Therapy.
Crossref
Crossref
Narayan Pant, Socorro Miranda-Hernandez, Catherine Rush, Jeffrey Warner & Damon P. Eisen. (2022) Non-Antimicrobial Adjuvant Therapy Using Ticagrelor Reduced Biofilm-Related Staphylococcus aureus Prosthetic Joint Infection. Frontiers in Pharmacology 13.
Crossref
Crossref
Ahmad Mourad, Thomas L. Holland & Nicholas A. Turner. (2022) Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?. Antimicrobial Agents and Chemotherapy 66:6.
Crossref
Crossref
Hayk Minasyan. (2022) Oxygen therapy for sepsis and prevention of complications. Acute and Critical Care 37:2, pages 137-150.
Crossref
Crossref
Joshua H. Jones & Richard D. Minshall. (2022) Endothelial Transcytosis in Acute Lung Injury: Emerging Mechanisms and Therapeutic Approaches. Frontiers in Physiology 13.
Crossref
Crossref
Patrizia Natale, Suetonia C Palmer, Valeria M Saglimbene, Marinella Ruospo, Mona Razavian, Jonathan C Craig, Meg J Jardine, Angela C Webster & Giovanni FM Strippoli. (2022) Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews 2022:2.
Crossref
Crossref
Elena Díaz-García, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz-Hernández, Jordi Solé-Violán, Carlos Rodríguez-Gallego, Ana Van-Den-Rym, Rebeca Pérez-de-Diego, Kapil Nanwani-Nanwani, Eduardo López-Collazo, Francisco García-Rio & Carolina Cubillos-Zapata. (2022) Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation. Frontiers in Immunology 13.
Crossref
Crossref
Stefan Agewall. (2022) Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient. European Heart Journal - Cardiovascular Pharmacotherapy 8:1, pages 1-3.
Crossref
Crossref
Jawad H Butt, Emil L Fosbøl, Thomas A Gerds, Kasper Iversen, Henning Bundgaard, Niels Eske Bruun, Anders R Larsen, Andreas Petersen, Paal S Andersen, Robert L Skov, Lauge Østergaard, Eva Havers-Borgersen, Gunnar H Gislason, Christian Torp-Pedersen, Lars Køber & Jonas B Olesen. (2022)
Ticagrelor and the risk of
Staphylococcus aureus
bacteraemia and other infections
. European Heart Journal - Cardiovascular Pharmacotherapy 8:1, pages 13-19.
Crossref
Crossref
Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel & Gilles Kauffenstein. (2022) Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID‐19‐associated thrombopathy. Journal of Thrombosis and Haemostasis 20:1, pages 17-31.
Crossref
Crossref
Ni Cheng, Yaping Zhang, M. Keegan Delaney, Can Wang, Yanyan Bai, Randal A. Skidgel & Xiaoping Du. (2021) Targeting Gα13-integrin interaction ameliorates systemic inflammation. Nature Communications 12:1.
Crossref
Crossref
Haoxuan Zhong, Maieryemu Waresi, Wei Zhang, Liping Han, Yikai Zhao, Yufei Chen, Peng Zhou, Lin Chang, Guanxing Pan, Bangwei Wu, Jian Li, Si Zhang, Haiming Shi, Xinping Luo, Wen Gao, Zhiyong Qi & Zhongren Ding. (2021) NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis. Biochemical Pharmacology 194, pages 114822.
Crossref
Crossref
Erlinda R Ulloa, Satoshi Uchiyama, Robert Gillespie, Victor Nizet & George Sakoulas. (2021)
Ticagrelor Increases Platelet-Mediated
Staphylococcus aureus
Killing, Resulting in Clearance of Bacteremia
. The Journal of Infectious Diseases 224:9, pages 1566-1569.
Crossref
Crossref
Michela Giustozzi, Hanne Ehrlinder, Dario Bongiovanni, Josip A. Borovac, Rui Azevedo Guerreiro, Aleksandra Gąsecka, Panteleimon E. Papakonstantinou & William A.E. Parker. (2021) Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment. Blood Reviews 50, pages 100864.
Crossref
Crossref
Qi Feng, Man Fung Tsoi, Yue Fei, Ching Lung Cheung & Bernard M. Y. Cheung. (2021) Use of ticagrelor and the risks of pneumonia and pneumonia-specific death in patients with non-acute coronary syndrome conditions: a population-based cohort study. Scientific Reports 11:1.
Crossref
Crossref
Victor Serebruany & Jean-Francois Tanguay. (2021) Infections Deaths in the PLATO Trial. TH Open 05:04, pages e503-e506.
Crossref
Crossref
Narayan Pant & Damon P. Eisen. (2021) Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related Staphylococcus aureus Prosthetic Joint Infections. Antibiotics 10:9, pages 1060.
Crossref
Crossref
Luca Esposito, Francesco Paolo Cancro, Angelo Silverio, Marco Di Maio, Patrizia Iannece, Antonio Damato, Carmine Alfano, Giuseppe De Luca, Carmine Vecchione & Gennaro Galasso. (2021) COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives. Oxidative Medicine and Cellular Longevity 2021, pages 1-13.
Crossref
Crossref
Xing-Ji Lian, Yi-Ning Dai, Jin-Hua Xue, Li-Huan Zeng, Li-Tao Wang, Ling Xue, Ji-Yan Chen, Ning Tan, Peng-Cheng He, Yuan-Hui Liu & Chong-Yang Duan. (2021) Ticagrelor and the risk of infections during hospitalization in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Atherosclerosis 331, pages 6-11.
Crossref
Crossref
A. D. Erlikh. (2021) Anticoagulants and antiaggregants in the COVID-19 era. Aterotromboz = Atherothrombosis:1, pages 58-66.
Crossref
Crossref
Victor L. Serebruany, Jean‐Francois Tanguay & Thomas A. Marciniak. (2021) The FDA and PLATO Investigators death lists: Call for a match. International Journal of Clinical Practice 75:7.
Crossref
Crossref
Ricky D. Turgeon, Erik Youngson & Michelle M. Graham. (2020) Risk of Pneumonia with Ticagrelor Versus Clopidogrel: a Population-Based Cohort Study. Journal of General Internal Medicine 36:7, pages 2158-2160.
Crossref
Crossref
Alexander J Rodríguez & Bo Abrahamsen. (2021) Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies. JBMR Plus 5:7.
Crossref
Crossref
Karla N. Samman, Pamela Mehanna, Emad Takla, Jean-Christophe Grenier, Mark Y. Chan, Renato D. Lopes, Megan Lee Neely, Tracy Y. Wang, L. Kristin Newby, Richard C. Becker, Marie Lordkipanidzé, Matthieu Ruiz, Julie G. Hussin & E. Marc Jolicœur. (2021) Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel. Cell Reports Medicine 2:6, pages 100299.
Crossref
Crossref
Hang Long Li, Qi Feng, Man Fung Tsoi, Yue Fei & Bernard M Y Cheung. (2021) Risk of infections in patients treated with ticagrelor vs. clopidogrel: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy 7:3, pages 171-179.
Crossref
Crossref
Demircan ÖZBALCI. (2021) COVID-19’DA ANTİKOAGÜLAN TEDAVİANTICOAGULANT THERAPY IN COVID-19. SDÜ Tıp Fakültesi Dergisi 28:COVİD-19 ÖZEL SAYI, pages 37-45.
Crossref
Crossref
Bo Huang, Yufeng Qian, Shujun Xie, Xianhua Ye, Hanwen Chen, Zhifeng Chen, Lihuan Zhang, Jinming Xu, Hu Hu, Shenglin Ma, Paul Héroux, Di Wang, Han-Ming Shen, Yihua Wu & Dajing Xia. (2020) Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway. Cellular & Molecular Immunology 18:5, pages 1278-1289.
Crossref
Crossref
Cheng-Han Lee, Hui-Wen Lin, Nan-Yao Lee, Sheng-Hsiang Lin & Yi-Heng Li. (2021) Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel. European Journal of Internal Medicine 85, pages 121-123.
Crossref
Crossref
Lourdes Vicent, Vanesa Bruña, Carolina Devesa, Iago Sousa-Casasnovas, Miriam Juárez, Luis Alcalá, Patricia Muñoz, Francisco Fernández-Avilés & Manuel Martínez-Sellés. (2021) Ticagrelor and Infection Risk in Patients with Coronary Artery Disease. Cardiology 146:6, pages 698-704.
Crossref
Crossref
Bernhard Wernly, David Erlinge, John Pernow & Zhichao Zhou. (2021) Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling?. American Journal of Physiology-Heart and Circulatory Physiology 320:1, pages H90-H94.
Crossref
Crossref
Ahmet Gürdal, Kudret Keskin, Mutlu Çağan Sümerkan, Gökhan Çetinkal, Hakan Kilci, Şükrü Çetin & Kadriye Orta Kılıçkesmez. (2020) Prognostic impact of infection in octogenarians with ST-segment elevation myocardial infarction. European Geriatric Medicine 11:6, pages 1073-1078.
Crossref
Crossref
Charles Feldman & Ronald Anderson. (2020) Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Frontiers in Immunology 11.
Crossref
Crossref
Ida Gregersen, Annika E. Michelsen, Ngoc Nguyen Lunde, Axel Åkerblom, Tatevik G. Lakic, Mona Skjelland, Karolina Ryeng Skagen, Richard C. Becker, Johan Lindbäck, Anders Himmelmann, Rigmor Solberg, Harald T. Johansen, Stefan K. James, Agneta Siegbahn, Robert F. Storey, Frederic Kontny, Pål Aukrust, Thor Ueland, Lars Wallentin & Bente Halvorsen. (2020) Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association 9:17.
Crossref
Crossref
Lior Lupu, Daniel Shepshelovich, Shmuel Banai, Rami Hershkoviz & Ofer Isakov. (2020) Effect of Ticagrelor on Reducing the Risk of Gram-Positive Infections in Patients With Acute Coronary Syndrome. The American Journal of Cardiology 130, pages 56-63.
Crossref
Crossref
Yen-Bo Su, Ming-Jen Kuo, Ting-Yu Lin, Chian-Shiu Chien, Yi-Ping Yang, Shih-Jie Chou & Hsin-Bang Leu. (2020) Cardiovascular manifestation and treatment in COVID-19. Journal of the Chinese Medical Association 83:8, pages 704-709.
Crossref
Crossref
Luca Valerio & Nicoletta Riva. (2020) Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and Treatment. Hämostaseologie 40:03, pages 301-310.
Crossref
Crossref
Alexandre Mansour, Mikael Roussel, Pascale Gaussem, Fabienne Nédelec-Gac, Adeline Pontis, Erwan Flécher, Christilla Bachelot-Loza & Isabelle Gouin-Thibault. (2020) Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation. Journal of Clinical Medicine 9:8, pages 2361.
Crossref
Crossref
Loukman Omarjee, Olivier Meilhac, Frédérique Perrot, Anne Janin & Guillaume Mahe. (2020) Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?. Clinical Immunology 216, pages 108468.
Crossref
Crossref
Alexandros Mitsios, Akrivi Chrysanthopoulou, Athanasios Arampatzioglou, Iliana Angelidou, Veroniki Vidali, Konstantinos Ritis, Panagiotis Skendros & Dimitrios Stakos. (2020) Ticagrelor Exerts Immune-Modulatory Effect by Attenuating Neutrophil Extracellular Traps. International Journal of Molecular Sciences 21:10, pages 3625.
Crossref
Crossref
Kunal Mahajan & Aditya Batra. (2020) Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era. Indian Heart Journal 72:3, pages 209-211.
Crossref
Crossref
Aleksandra Gasecka, Rienk Nieuwland, Monika Budnik, Françoise Dignat‐George, Ceren Eyileten, Paul Harrison, Romaric Lacroix, Aurélie Leroyer, Grzegorz Opolski, Kinga Pluta, Edwin van der Pol, Marek Postuła, Pia Siljander, Jolanta M. Siller‐Matula & Krzysztof J. Filipiak. (2020) Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. Journal of Thrombosis and Haemostasis 18:3, pages 609-623.
Crossref
Crossref
Giorgio Aquila, Francesco Vieceli Dalla Sega, Luisa Marracino, Rita Pavasini, Laura Sofia Cardelli, Anna Piredda, Alessandra Scoccia, Valeria Martino, Francesca Fortini, Ilaria Bononi, Fernanda Martini, Marco Manfrini, Antonio Pannuti, Roberto Ferrari, Paola Rizzo & Gianluca Campo. (2020) Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences 21:5, pages 1576.
Crossref
Crossref
Alexandre Mansour, Christilla Bachelot-Loza, Nicolas Nesseler, Pascale Gaussem & Isabelle Gouin-Thibault. (2020) P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation. International Journal of Molecular Sciences 21:4, pages 1391.
Crossref
Crossref
M. Dalén, F. Biancari, A. Perrotti, G. Mariscalco, F. Onorati, G. Faggian, I. Franzese, A. Salsano, F. Santini, V.G. Ruggieri, D. Maselli, S. Nardella, G. Santarpino, T. Fischlein, M. Saccocci, M. Zanobini, F. Musumeci, R. Gherli, A.S. Rubino, M. De Feo, C. Bancone, F. Nicolini, E.-M. Kinnunen, T. Tauriainen, D. Reichart, T. Demal, G. Gatti, S. Khodabandeh & M. Holm. (2020) Infectious complications in patients receiving ticagrelor or clopidogrel before coronary artery bypass grafting. Journal of Hospital Infection 104:2, pages 236-238.
Crossref
Crossref
Barbara Jones & Grant Waterer. (2020) Advances in community-acquired pneumonia. Therapeutic Advances in Infectious Disease 7, pages 204993612096960.
Crossref
Crossref
Thor Ueland, Axel Åkerblom, Tatevik Ghukasyan, Annika E. Michelsen, Richard C. Becker, Maria Bertilsson, Andrzej Budaj, Jan H. Cornel, Anders Himmelmann, Stefan K. James, Agneta Siegbahn, Robert F. Storey, Frederic Kontny, Pål Aukrust & Lars Wallentin. (2020) ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. Atherosclerosis 293, pages 35-41.
Crossref
Crossref
Gianluca Rigatelli, Marco Zuin, Alberto Rigatelli, Luca Conte & Loris Roncon. (2019) Protective activity of Ticagrelor against bacterial infection in acute myocardial infarction patients. European Journal of Internal Medicine 70, pages e19-e21.
Crossref
Crossref
Axel Åkerblom, Stefan K. James, Tatevik G. Lakic, Richard C. Becker, Christopher P. Cannon, Philippe G. Steg, Anders Himmelmann, Hugo A. Katus, Robert F. Storey, Lars Wallentin, W. Douglas Weaver & Agneta Siegbahn. (2019) Interleukin‐18 in patients with acute coronary syndromes. Clinical Cardiology 42:12, pages 1202-1209.
Crossref
Crossref
Ruth Heying, Thomas Vanassche & Philippe Moreillon. (2019) Are Antiplatelet Agents Beneficial in Prevention of Infective Endocarditis?. JAMA Cardiology 4:11, pages 1177.
Crossref
Crossref
Shio-Shin Jean, Shun-Chung Hsueh, Juey-Jen Hwang & Po-Ren Hsueh. (2019) Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci. Journal of Microbiology, Immunology and Infection 52:4, pages 513-515.
Crossref
Crossref
Freek W.A. Verheugt, Jurriën M. ten Berg, Robert F. Storey, Thomas Cuisset & Christopher B. Granger. (2019) Antithrombotics. Journal of the American College of Cardiology 74:5, pages 699-711.
Crossref
Crossref
Hans Kossmann, Christoph Rischpler, Franziska Hanus, Stephan G. Nekolla, Karl P. Kunze, Katharina Götze, Alexander Goedel, Hendrik Sager, Adnan Kastrati, Daniel Sinnecker, Christian Kupatt, Tareq Ibrahim, Markus Schwaiger, Karl-Ludwig Laugwitz & Ralf J. Dirschinger. (2019) Monocyte-platelet aggregates affect local inflammation in patients with acute myocardial infarction. International Journal of Cardiology 287, pages 7-12.
Crossref
Crossref
Axel Åkerblom, Daniel M. Wojdyla, Lars Wallentin, Stefan K. James, Flávio de Souza Brito, Philippe Gabriel Steg, Christopher P. Cannon, Hugo A. Katus, Anders Himmelmann, Robert F. Storey, Richard C. Becker & Renato D. Lopes. (2019) Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. American Heart Journal 213, pages 57-65.
Crossref
Crossref
Charalambos Vlachopoulos, Christos Georgakopoulos, Panagiota Pietri, Nikolaos Ioakeimidis, Michael Koutouzis, Sophia Vaina, Konstantinos Aznaouridis, Konstantinos Toutouzas, George Latsios, Dimitrios Terentes‐Printzios, Aggeliki Rigatou & Dimitris Tousoulis. (2019) Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease. Journal of the American Heart Association 8:12.
Crossref
Crossref
David Manuel Leistner, Charlotte Münch, Julia Steiner, Alexander Lauten, Ulf Landmesser & Barbara Elisabeth Stähli. (2019) Effect on Outcomes: Infections Complicating Percutaneous Coronary Interventions in Patients ≥80 Years of Age. The American Journal of Cardiology 123:11, pages 1806-1811.
Crossref
Crossref
Patrizio Lancellotti, Lucia Musumeci, Nicolas Jacques, Laurence Servais, Eric Goffin, Bernard Pirotte & Cécile Oury. (2019) Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria. JAMA Cardiology 4:6, pages 596.
Crossref
Crossref
Denise C. Cornelius, Cedar H. Baik, Olivia K. Travis, Dakota L. White, Cassandra M. Young, W. Austin Pierce, Corbin A. Shields, Bibek Poudel & Jan M. Williams. (2019)
NLRP
3 inflammasome activation in platelets in response to sepsis
. Physiological Reports 7:9, pages e14073.
Crossref
Crossref
Sascha Marx, Yong Xiao, Marcel Baschin, Maximilian Splittstöhser, Robert Altmann, Eileen Moritz, Gabriele Jedlitschky, Sandra Bien-Möller, Henry W.S. Schroeder & Bernhard H. Rauch. (2019) The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. Cancers 11:4, pages 569.
Crossref
Crossref
Marie Scully & Marcel Levi. (2019) How we manage haemostasis during sepsis. British Journal of Haematology 185:2, pages 209-218.
Crossref
Crossref
Choongki Kim, Dong-Ho Shin, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Juhee Park, Hyeyeong Lee, Dong-Sook Kim, Sang-Kwon Oh & Yangsoo Jang. (2019) One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data. Journal of Cardiology 73:3, pages 191-197.
Crossref
Crossref
Davide Capodanno, Roxana Mehran, Marco Valgimigli, Usman Baber, Stephan Windecker, Pascal Vranckx, George Dangas, Fabiana Rollini, Takeshi Kimura, Jean-Philippe Collet, C. Michael Gibson, Philippe Gabriel Steg, Renato D. Lopes, Hyeon-Cheol Gwon, Robert F. Storey, Francesco Franchi, Deepak L. Bhatt, Patrick W. Serruys & Dominick J. Angiolillo. (2018) Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nature Reviews Cardiology 15:8, pages 480-496.
Crossref
Crossref
Travis R. Sexton, Guoying Zhang, Tracy E. Macaulay, Leigh A. Callahan, Richard Charnigo, Olga A. Vsevolozhskaya, Zhenyu Li & Susan Smyth. (2018) Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia. JACC: Basic to Translational Science 3:4, pages 435-449.
Crossref
Crossref
Yuhui Wang, Yaqi Ouyang, Baoyan Liu, Xiaochun Ma & Renyu Ding. (2018) Platelet activation and antiplatelet therapy in sepsis: A narrative review. Thrombosis Research 166, pages 28-36.
Crossref
Crossref
Kudret Keskin, Gökhan Çetinkal, Serhat Sığırcı, Süleyman Sezai Yıldız, Şükrü Çetin, Ahmet Gürdal, Betül Balaban Kocaş & Kadriye Orta Kılıçkesmez. (2018) The impact of infection on mortality in octogenarians who were admitted due to acute coronary syndrome. Archives of Gerontology and Geriatrics 76, pages 48-53.
Crossref
Crossref
Wael Sumaya, Lars Wallentin, Stefan K James, Agneta Siegbahn, Katja Gabrysch, Maria Bertilsson, Anders Himmelmann, Ramzi A Ajjan & Robert F Storey. (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. European Heart Journal 39:13, pages 1078-1085.
Crossref
Crossref
Richard C. BeckerTravis SextonSusan S. Smyth. (2018) Translational Implications of Platelets as Vascular First Responders. Circulation Research 122:3, pages 506-522.
Crossref
Crossref
Antoine Dewitte, Sébastien Lepreux, Julien Villeneuve, Claire Rigothier, Christian Combe, Alexandre Ouattara & Jean Ripoche. (2017) Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients?. Annals of Intensive Care 7:1.
Crossref
Crossref
Karolina Akinosoglou, Spyridoula Theodoraki, Ioanna Xanthopoulou, Angelos Perperis, Theologia Gkavogianni, Aikaterini Pistiki, Evangelos Giamarellos-Bourboulis & Charalambos A Gogos. (2017) Platelet reactivity in sepsis syndrome: results from the PRESS study. European Journal of Clinical Microbiology & Infectious Diseases 36:12, pages 2503-2512.
Crossref
Crossref
Han Saem Jeong, Soon Jun Hong, Sang-A Cho, Jong-Ho Kim, Jae Young Cho, Seung Hun Lee, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu & Do-Sun Lim. (2017) Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting. JACC: Cardiovascular Interventions 10:16, pages 1646-1658.
Crossref
Crossref
Angela Lowenstern, Robert F. Storey, Megan Neely, Jie-Lena Sun, Dominick J. Angiolillo, Christopher P. Cannon, Anders Himmelmann, Kurt Huber, Stefan K. James, Hugo A. Katus, Joao Morais, Agneta Siegbahn, Phillippe Gabriel Steg, Lars Wallentin & Richard C. Becker. (2017) Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis 44:2, pages 145-153.
Crossref
Crossref
Hyun Jung Kim, Eun-Hye Choi, Yeon Jung Lim & Hong Ryang Kil. (2017) The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease. Journal of Korean Medical Science 32:7, pages 1147.
Crossref
Crossref
Dorien Kiers, Wouter A. van der Heijden, Lisa van Ede, Jelle Gerretsen, Quirijn de Mast, Andre J. van der Ven, Saloua el Messaoudi, Gerard A. Rongen, Marc Gomes, Matthijs Kox, Peter Pickkers & Niels P. Riksen. (2017) A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia. Thrombosis and Haemostasis 117:09, pages 1798-1807.
Crossref
Crossref
Wael Sumaya & Robert F. Storey. (2017) Ticagrelor. Interventional Cardiology Clinics 6:1, pages 49-55.
Crossref
Crossref
Lina Badimona & Gemma Vilahur. (2017) Efectos cardioprotectores del ticagrelor. Revista Española de Cardiología Suplementos 17, pages 3-8.
Crossref
Crossref
Felix Fluri, Bernhard Nieswandt, Guido Stoll & Christoph Kleinschnitz. 2017. Platelets, Haemostasis and Inflammation. Platelets, Haemostasis and Inflammation
253
274
.
Gemma VilahurManuel GutiérrezLaura CasaniLourdes VarelaAntoni CapdevilaGuillem Pons-LladóFrancesc CarrerasLeif CarlssonAlberto HidalgoLina Badimon. (2016) Protective Effects of Ticagrelor on Myocardial Injury After Infarction. Circulation 134:22, pages 1708-1719.
Crossref
Crossref
Keun-Ho Park, Myung Ho Jeong, Youngkeun Ahn, Tae Hoon Ahn, Ki Bae Seung, Dong Joo Oh, Dong-Joo Choi, Hyo-Soo Kim, Hyeon Cheol Gwon, In Whan Seong, Kyung Kuk Hwang, Shung Chull Chae, Kwon-Bae Kim, Young Jo Kim, Kwang Soo Cha, Seok Kyu Oh & Jei Keon Chae. (2016) Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry—National Institute of Health. International Journal of Cardiology 215, pages 193-200.
Crossref
Crossref
Sven Nylander & Rainer Schulz. (2016)
Effects of P2Y
12
receptor antagonists beyond platelet inhibition – comparison of ticagrelor with thienopyridines
. British Journal of Pharmacology 173:7, pages 1163-1178.
Crossref
Crossref
Mark R. ThomasSamuel N. OutteridgeRamzi A. AjjanFladia PhoenixGurpreet K. SanghaRachael E. FaulknerRosemary EcobHeather M. JudgeHaroon KhanLaura E. WestDavid H. DockrellIan SabroeRobert F. Storey. (2015)
Platelet P2Y
12
Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model
. Arteriosclerosis, Thrombosis, and Vascular Biology 35:12, pages 2562-2570.
Crossref
Crossref
Cemil Zencir, Mahmut Akpek, Sebnem Senol, Mithat Selvi, Sevil Onay, Mustafa Cetin, Cagdas Akgullu, Huseyin Elbi & Hasan Gungor. (2015) Association between hematologic parameters and in‐hospital mortality in patients with infective endocarditis. The Kaohsiung Journal of Medical Sciences 31:12, pages 632-638.
Crossref
Crossref
T. N. A. van den Berg, S. El Messaoudi, G. A. Rongen, P. H. H. van den Broek, A. Bilos, A. R. T. Donders, M. E. Gomes & N. P. Riksen. (2015) Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo. PLOS ONE 10:10, pages e0137560.
Crossref
Crossref
Rahajeng N. Tunjungputri, Andre J. van der Ven, Niels Riksen, Gerard Rongen, Sabine Tacke, T. N. A. van den Berg, Rob Fijnheer, Marc E. Gomes, Charles A. Dinarello, Frank L. van de Veerdonk, M. Hussein Gasem, Mihai G. Netea, Leo A. B. Joosten, Philip G. de Groot & Quirijn de Mast. (2017) Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses. Thrombosis and Haemostasis 113:05, pages 1035-1045.
Crossref
Crossref
Khalaf F. Alsharif, Mark R. Thomas, Heather M. Judge, Haroon Khan, Lynne R. Prince, Ian Sabroe, Victoria C. Ridger & Robert F. Storey. (2015) Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis. Vascular Pharmacology 71, pages 201-207.
Crossref
Crossref
Nicholas B. Norgard & James J. DiNicolantonio. (2015) P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use. Therapeutic Advances in Chronic Disease 6:4, pages 204-218.
Crossref
Crossref
Cheng-Ming Tsao, Shung-Tai Ho & Chin-Chen Wu. (2015) Coagulation abnormalities in sepsis. Acta Anaesthesiologica Taiwanica 53:1, pages 16-22.
Crossref
Crossref
Sohita Dhillon. (2015) Ticagrelor: A Review of Its Use in Adults with Acute Coronary Syndromes. American Journal of Cardiovascular Drugs 15:1, pages 51-68.
Crossref
Crossref
Mark Thomas & Robert Storey. (2017) Effect of P2Y12 inhibitors on inflammation and immunity. Thrombosis and Haemostasis 114:09, pages 490-497.
Crossref
Crossref
Mark Thomas & Robert Storey. (2017) The role of platelets in inflammation. Thrombosis and Haemostasis 114:09, pages 449-458.
Crossref
Crossref
Karin Müller, Madhumita Chatterjee, Dominik Rath & Tobias Geisler. (2017) Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD. Thrombosis and Haemostasis 114:09, pages 498-518.
Crossref
Crossref
Michelle J. Taylor, Tahir Mehmood & Justin D. Kreuter. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
419
432
.
L. Wallentin, A. Himmelmann, R. F. Storey, P. G. Steg & R. A. Harrington. (2014) Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value. Thrombosis and Haemostasis 112:1.
Crossref
Crossref
Mark R. Thomas & Robert F. Storey. (2013) Impact of Aspirin Dosing on the Effects of P2Y12 Inhibition in Patients with Acute Coronary Syndromes. Journal of Cardiovascular Translational Research 7:1, pages 19-28.
Crossref
Crossref
Lars Wallentin, Anders Himmelmann, Robert F. Storey, Philippe Steg & Robert A. Harrington. (2017) Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value. Thrombosis and Haemostasis 112:07, pages 12-14.
Crossref
Crossref
Sacha de Stoppelaar, Cornelis van ’t Veer & Tom van der Poll. (2017) The role of platelets in sepsis. Thrombosis and Haemostasis 112:10, pages 666-677.
Crossref
Crossref
Piotr Adamski, Marek Koziński, Małgorzata Ostrowska, Tomasz Fabiszak, Eliano Navarese, Przemysław Paciorek, Grzegorz Grześk & Jacek Kubica. (2017) Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors. Thrombosis and Haemostasis 112:08, pages 224-242.
Crossref
Crossref